spike
glycoprotein
thought
play
complex
central
role
biolog
pathogenesi
sar
coronaviru
infect
studi
recombin
protein
correspond
residu
sarscov
protein
express
escherichia
coli
purifi
near
homogen
immun
proteinspecif
balbc
antisera
mab
induc
confirm
use
elisa
western
blot
ifa
sever
balbc
mab
found
effect
neutral
infect
vero
cell
sarscov
dosedepend
manner
systemat
epitop
map
show
neutral
mab
recogn
peptid
correspond
residu
spdvdlgdisgina
locat
second
heptad
repeat
region
sarscov
spike
protein
peptid
could
specif
inhibit
interact
neutral
mab
spike
protein
dosedepend
manner
neutral
mab
control
mab
could
specif
interact
dosedepend
manner
result
implic
second
heptad
repeat
region
spike
protein
could
good
target
vaccin
develop
sarscov
welldocu
strong
evid
support
new
emerg
coronaviru
cov
etiolog
link
outbreak
sever
acut
respiratori
syndrom
sar
asia
canada
last
year
sar
associ
cov
sever
major
structur
protein
membran
spike
glycoprotein
nucleocapsid
n
envelop
e
protein
structur
protein
thought
protein
multifunct
protein
play
complex
central
role
biolog
pathogenesi
sar
infect
major
known
properti
function
coroaviru
protein
found
includ
bind
specif
receptor
glycoprotein
surfac
host
cell
b
bind
receptor
protein
possibl
conform
chang
caus
induct
fusion
viral
envelop
cell
membran
c
cell
fusion
facilit
viral
rna
entri
host
target
induct
neutral
antibodi
e
elicit
cellmedi
immun
demonstr
ntermin
amino
acid
domain
associ
alter
antigen
virul
actual
consider
divers
length
nucleotid
sequenc
deriv
differ
group
coronavirus
sometim
even
within
differ
strain
singl
famili
coronaviru
align
amino
acid
sequenc
sarscov
gi
spike
protein
gi
reveal
ident
indic
consider
divers
protein
sarscov
human
coronaviru
rapid
treatment
sar
patient
urgent
need
therefor
necessari
develop
effect
safe
vaccin
prevent
infect
sarscov
studi
evalu
neutral
effect
mab
spike
protein
sarscov
map
interact
region
spike
protein
neutral
mab
anticip
find
conserv
neutral
epitop
spike
protein
use
vaccin
target
therapeut
agent
sarscov
escherichia
coli
plasmid
use
clone
sar
spike
protein
escherichia
coli
star
use
express
protein
control
phage
lac
promot
plasmid
vector
qiagen
use
express
histidinetag
fuse
carboxylterminu
protein
gener
recombin
plasmid
rs
mrna
extract
vero
cell
infect
sarscov
isol
suspectedsar
patient
use
qiaamp
viral
rna
mini
kit
qiagen
accord
instruct
manual
extract
mrna
resuspend
te
buffer
mm
triscl
mm
edta
ph
use
templat
rtpcr
amplif
amino
acid
sar
coronaviru
one
pair
primer
correspond
nucleotid
sarscov
spike
proteinencod
sequenc
design
base
publish
sequenc
genbank
access
pcr
carri
initi
denatur
step
min
follow
cycl
denatur
min
anneal
min
extens
min
final
prolong
extens
step
min
amplifi
code
sequenc
insert
dtopo
vector
gener
plasmid
dtopo
recombin
plasmid
dna
sequenc
correct
code
sequenc
confirm
abil
antisera
immun
mice
inhibit
sarscov
viru
infect
vero
cell
assess
viru
neutral
assay
prepar
viru
stock
solut
neutral
assay
vero
cell
infect
sarscov
genbank
access
gi
incub
co
day
infecti
viru
stock
calcul
use
method
reed
muench
viru
stock
solut
aliquot
individu
tube
store
viru
neutral
test
vero
cellsml
inocul
onto
tissu
cultur
plate
falcon
flexibl
plate
co
overnight
preimmun
serum
antiserum
balbc
rais
recombin
sarscov
spike
protein
pretreat
min
destroy
heatlabil
nonspecif
viral
inhibitori
substanc
dilut
begin
dilut
dmem
mainten
medium
ad
well
contain
viru
volum
ml
mab
dilut
lg
per
ml
equal
volum
serum
mab
solut
testviru
dilut
mix
incub
h
serumviru
mixtur
viru
control
sera
inocul
vero
cultur
plate
prewash
dmem
mainten
medium
empti
prior
addit
serumviru
mixtur
cultur
plate
absorpt
viru
entryinhibit
assay
h
well
wash
dmem
mainten
medium
fetal
calf
serumdmem
buffer
ad
h
incub
well
wash
twice
pb
ph
lyse
buffer
ad
micropl
store
sdspagewestern
blot
analysi
presenc
viru
replic
viru
neutral
titer
calcul
sarscov
viral
protein
detect
sdspagewestern
blot
analysi
identif
purifi
rs
protein
equal
amount
lysat
escherichia
coli
contain
mock
induc
recombin
spike
protein
purif
protein
boil
load
onto
sdspage
describ
purifi
fusion
protein
detect
mous
antihistidin
antibodi
amersham
pharmacia
biotech
western
immunoblot
analysi
confirm
neutral
effect
antiserum
recombin
sarscov
spike
protein
equal
amount
virusinfect
cell
lysat
total
lysat
boil
sampl
buffer
mm
trishcl
ph
mm
dtt
sd
glycerol
brophenol
blue
min
load
onto
sdspolyacrylamid
gel
electrophoresi
sdspage
specif
protein
detect
balbc
polyclon
antibodi
laboratori
mous
antib
actin
monoclon
antibodi
sigma
cat
western
blot
describ
previous
recombin
protein
express
purifi
use
denatur
method
describ
previous
modif
brief
escherichia
coli
bacteria
contain
plasmid
pet
use
prokaryot
express
purif
histidinetag
protein
dialysi
brief
centrifug
sigma
centrifug
rpm
min
c
supernat
quickli
frozen
liquid
nitrogen
store
normal
healthi
balbc
rat
sera
obtain
anim
center
institut
prevent
medicin
nation
defens
medic
center
taiwan
anim
confirm
healthi
licens
veterinarian
antisera
spike
protein
prepar
three
subcutan
inocul
lg
recombin
protein
mix
freund
adjuv
rat
balbc
respect
complet
adjuv
incomplet
adjuv
first
second
third
inocul
respect
interv
month
one
month
last
immun
anim
bled
sera
centrifug
g
min
sigma
centrifug
nr
rotor
h
agglutin
room
temperatur
antisera
collect
mix
glycerol
store
immun
balbc
mice
receiv
intraperiton
ip
inject
lg
recombin
spike
protein
rs
pb
emulsifi
equal
volum
complet
freund
adjuv
interv
week
week
booster
inject
given
except
use
incomplet
freund
adjuv
instead
three
week
third
inject
final
booster
contain
lg
antigen
administ
via
ip
inject
fusion
perform
day
last
inject
spleen
cell
donor
mous
hybridoma
secret
antispik
antibodi
gener
accord
standard
procedur
hybridoma
coloni
screen
elisa
select
clone
subclon
limit
dilut
method
immunoglobulin
class
subclass
determin
use
subtyp
kit
roch
diagnost
penzberg
germani
ascit
fluid
produc
pristaneprim
balbc
mice
monoclon
antibodi
purifi
use
protein
affin
chromatographi
store
lg
mab
per
ml
check
sarscov
spike
proteinrecogn
capabl
mab
recombin
spike
protein
ifa
perform
briefli
vero
monolay
cell
infect
sarscov
wash
three
time
pb
fix
acetonemethanol
mixtur
min
room
temperatur
block
skim
milk
pb
h
room
temperatur
ifa
assay
perform
stain
monolay
view
immunofluoresc
microscop
leica
dmirb
microtit
plate
falcon
coat
antigen
lgml
purifi
recombin
protein
amino
acid
carbon
buffer
ph
overnight
bound
mab
detect
use
secondari
antibodi
goat
antimous
igghrp
h
wash
abt
boehring
tmb
opd
ophenylediamin
sigma
substrat
ad
stay
min
abt
min
tmb
min
opd
room
temperatur
reaction
stop
h
specif
sarscov
igg
detect
od
abt
od
tmb
endpoint
read
experi
perform
describ
previous
sera
alway
assay
duplic
plate
also
includ
air
blank
well
neg
control
posit
control
competitiveinhibit
assay
differ
concentr
synthet
peptid
spsgncd
spsgiaa
spdlg
illustr
tabl
mix
mab
transfer
recombin
proteinco
plate
incub
h
wash
plate
incub
hrpconjug
goat
antimous
ig
antibodi
pbst
icn
biomed
min
procedur
describ
follow
synthet
peptid
sp
lg
label
digoxigenin
roch
acidnhydroxysuccinimid
ester
cat
accord
instruct
manual
label
peptid
purifi
passag
nuctrap
purif
column
strategen
cat
accord
manufactur
instruct
concentr
lgll
use
centricon
centrifug
filtur
devic
millipor
cat
accord
instruct
manual
gel
migrat
shift
assay
digoxigeninlabel
probe
sp
dig
incub
mab
mab
mab
presenc
absenc
cell
lysat
vero
cell
lysat
total
lysat
sarscov
virusinfect
cell
lysat
total
lysat
reaction
buffer
mm
hepe
ph
mm
kcl
glycerol
mm
mgcl
mm
dithiothreitol
min
room
temperatur
sampl
dye
tbe
glycerol
bromophenol
blue
xylen
cyanol
ad
probeprotein
complex
separ
free
probe
electrophoresi
nativ
polyacrylamid
gel
electrophoresi
gel
transfer
hybondc
extra
membran
membran
block
incub
antidigoxigeninpod
fab
fragment
roch
cat
final
wash
block
buffer
membran
develop
ecl
western
blot
reagent
describ
western
immunoblot
analysi
microtit
plate
coat
differ
fusion
protein
synthet
peptid
long
peptid
np
lgwell
carbon
buffer
overnight
incub
dilut
mab
pb
h
block
bound
mab
detect
use
secondari
antibodi
goat
antimous
igghrp
h
wash
abt
boehring
tmb
substrat
ad
stay
min
abt
min
tmb
room
temperatur
reaction
stop
n
h
specif
sarscov
igg
detect
od
abt
od
tmb
endpoint
read
plate
also
includ
blank
neg
control
background
reactiv
possibl
crossreact
assess
analyz
preimmun
serum
specimen
healthi
rabbit
mice
rat
cutoff
valu
set
sd
odn
mean
od
record
preimmun
serum
mock
specimen
od
greater
calcul
threshold
od
regard
posit
sera
other
regard
neg
synthet
peptid
recombin
fragment
use
monoclon
antibodi
map
recombin
fragment
fragment
residu
link
gli
linker
tm
fragment
residu
express
escherichia
coli
fragment
residu
link
gli
linker
tm
fragment
residu
express
escherichia
coli
fragment
residu
link
human
fc
fragment
express
baculoviru
system
residu
express
escherichia
coli
residu
express
escherichia
coli
peptid
sequenc
residu
overlap
residu
kelowna
taipei
roc
tabl
code
sequenc
correspond
amino
acid
protein
sar
coronaviru
amplifi
use
rtpcr
clone
prokaryot
expression
vector
contain
tag
code
sequenc
produc
plasmid
express
recombin
protein
induc
iptg
recombin
protein
purifi
near
homogen
use
ni
nta
agaros
affin
chromatographi
figur
lane
rs
purifi
recombin
protein
confirm
mous
antihistidin
antibodi
describ
materi
method
shown
figur
purifi
rs
protein
inde
histidinetag
fusion
protein
determin
whether
escherichia
coli
express
recombin
spike
protein
could
conserv
immunolog
biolog
properti
sar
covspecif
antibodi
sar
patient
use
detect
purifi
recombin
elisa
use
rs
coat
antigen
elisa
perform
measur
sarsspecif
igg
sera
control
suspect
sar
patient
recombin
protein
rs
recogn
igg
sar
patient
ptshi
ptyea
control
sera
figur
short
recombin
protein
could
detect
sarsspecif
igg
sarscov
infect
patient
implic
rs
might
conserv
antigen
character
epitop
polyclon
antibodi
rat
balbc
sera
rais
purifi
rs
protein
test
confirm
recogn
sar
coronaviru
spike
protein
use
western
blot
indirect
immunofluoresc
assay
ifa
figur
panel
b
illustr
figur
mous
antir
antiserum
recogn
spike
glycoprotein
sarscovinfect
vero
cell
lysat
lane
antibodi
reactiv
titer
sarscov
spike
protein
elisa
found
rat
antir
igg
balbc
antir
igg
last
immun
data
shown
mab
rais
rs
assay
capabl
recogn
sarscov
spike
protein
use
ifa
assay
illustr
figur
mab
mab
specif
recogn
sarscov
virusinfect
vero
cell
panel
e
f
character
monoclon
antibodi
isotyp
mab
analyz
use
isostrip
mous
mab
isotyp
kit
roch
shown
tabl
mab
sar
patient
serum
also
recogn
sarscov
infect
vero
cell
ifa
assay
figur
panel
h
sera
mous
preimmun
control
patient
panel
g
taken
result
togeth
antisera
could
recogn
bind
spike
protein
sarscov
order
character
neutral
antisera
rais
recombin
sar
spike
protein
virusneutr
assay
perform
test
efficaci
balbc
mice
mab
rais
rs
shown
figur
tabl
result
reveal
recombin
rs
protein
maintain
conserv
antigen
epitop
sarscov
spike
glycoprotein
antisera
mab
rais
recombin
protein
capabl
neutral
infect
vero
cell
sarscov
elucid
mechan
neutral
well
map
neutral
epitop
spike
protein
systemat
epitopemap
assay
perform
use
synthet
peptid
deriv
protein
mab
elisa
shown
figur
neutral
mab
mab
bound
recombin
protein
fragment
common
transmembran
domain
epitop
map
shown
neutral
mab
recogn
peptid
cover
residu
cb
illustr
figur
actual
neutral
mab
specif
bound
individu
synthet
peptid
compris
acid
spdvdlgdisgina
locat
tip
one
heptad
repeat
region
sarscov
spike
protein
figur
bind
antibodi
heptad
region
specif
suffici
neutral
infect
vero
cell
sarscov
sinc
strong
neutral
mab
mab
bound
peptid
weak
nonneutr
mab
figur
result
studi
reveal
mab
bind
heptad
repeat
region
spike
protein
could
suffici
neutral
infect
sarscov
order
reveal
neutral
mechan
mab
spike
protein
sarscov
differ
synthet
peptid
mimick
neutral
epitop
correspond
amino
acid
spike
protein
mutant
control
use
test
competit
abil
inhibit
interact
mab
spike
protein
illustr
figur
peptid
control
peptid
inhibit
neutral
mab
mab
bind
spike
protein
dosedepend
manner
meanwhil
peptid
could
effici
inhibit
nonneutr
mab
mab
bind
spike
protein
competit
inhibit
mabsspik
protein
interact
specif
sinc
control
peptid
spsgncd
spsgiaa
spdlg
inhibit
effect
figur
character
interact
elisa
illustr
figur
neutral
mab
differenti
featur
bind
synthet
peptid
mimick
variou
amino
acid
residu
heptad
repeat
region
spike
protein
exampl
mab
mab
bound
peptid
almost
equal
wild
type
peptid
mab
result
data
implic
neutral
mab
inhibit
infect
sarscov
special
bind
amino
acid
residu
locat
region
spike
protein
neutral
monoclon
antibodi
bind
synthet
peptid
mimick
amino
acid
residu
region
spike
protein
dosedepend
manner
aforement
result
implic
mab
might
neutral
infect
cell
sarscov
special
bind
region
spike
protein
test
hypothesi
emsa
assay
perform
examin
bind
character
mab
synthet
peptid
experi
use
digoxigeninlabel
synthet
peptid
sp
dig
probe
bind
protein
migrat
faster
polyacrylamid
gel
bind
protein
antibodi
peptideantibodi
complex
migrat
slower
free
peptid
free
peptid
peptideantibodi
complex
bind
podconjug
antidigoxigenin
secondari
antibodi
detect
ecl
substrat
illustr
figur
synthet
peptid
probe
sp
dig
repres
heptad
repeat
region
special
bound
neutral
mab
mab
dosedepend
manner
lane
nonneutr
mab
mab
lane
lysat
sarscov
infect
cell
ad
peptidemab
complex
compet
sarscov
virusinfect
cell
lysat
dosedepend
manner
lane
result
studi
show
mab
specif
recogn
heptad
repeat
region
might
neutral
infect
cell
sarscov
dosedepend
manner
differenti
featur
thu
implic
might
practic
prevent
human
infect
sarscov
recombin
subunit
vaccin
synthet
peptid
mimick
amino
acid
residu
heptad
repeat
region
spike
protein
sar
pandem
great
impact
health
econom
integr
countri
world
associ
transmiss
novel
pathogen
effect
vaccin
drug
import
research
candid
prevent
therapi
novel
viral
diseas
therefor
infect
viral
entri
mechan
import
target
work
present
studi
examin
biolog
properti
escherichia
coli
express
recombin
spike
protein
immunolog
properti
small
anim
antisera
rais
recombin
rs
protein
compar
obtain
sar
patient
mous
mab
gener
immun
recombin
spike
protein
evalu
biolog
activ
viru
neutral
sarscov
map
character
viru
neutral
epitop
sinc
sarscov
spike
protein
glycoprotein
could
argu
lack
protein
modif
prokaryot
cell
express
system
would
retain
nativ
conform
fold
protein
howev
shown
figur
purifi
recombin
protein
appear
recogn
antibodi
sera
sarscov
infect
patient
antisera
induc
recombin
rs
protein
tabl
incub
dilut
mab
pbst
h
block
bound
mab
b
c
detect
elisa
describ
materi
method
error
bar
indic
standard
deviat
duplic
test
plate
also
includ
blank
well
neg
control
recogn
captur
sarscov
spike
glycoprotein
western
blot
ifa
captur
sandwich
elisa
figur
b
data
shown
actual
sever
line
evid
demonstr
spike
protein
sarscov
interact
human
receptor
glycosylationindepend
manner
recombin
spike
protein
express
escherichia
coli
could
induc
protect
immun
sarscov
therefor
recombin
rs
protein
valuabl
induc
antisera
actual
recogn
major
characterist
biolog
function
spike
protein
shown
figur
even
though
might
lose
minor
conformationdepend
antigen
epitop
relat
glycosyl
smallanim
antisera
rais
recombin
spike
protein
evalu
neutral
effect
vero
cell
infect
sarscov
rabbit
antisera
gener
recombin
full
immun
potent
viru
neutral
activ
compar
sar
patient
sera
data
shown
meanwhil
mous
immun
rs
gener
viru
neutral
antibodi
sarscov
present
studi
mab
recombin
spike
protein
strong
neutral
effect
seen
viru
neutral
assay
mab
littl
neutral
effect
tabl
figur
support
differ
mab
variou
bind
activ
synthet
peptid
mimick
spike
protein
figur
lg
per
cell
monoclon
antibodi
recogn
epitop
residu
could
suffici
neutral
sarscov
infect
block
viru
entri
vero
cell
neutral
epitop
residu
map
studi
locat
tip
heptad
repeat
region
spike
protein
hrc
domain
thu
mab
like
neutral
infect
sarscov
inhibit
viru
entri
vero
cell
mechan
differ
receptor
bind
block
mechan
report
other
viralcellular
membran
fusion
mediat
sever
type
viral
fusion
protein
exampl
hiv
could
inhibit
peptid
mimick
either
hrn
hrc
region
author
suggest
region
crucial
entri
sarscov
support
assumpt
sarscov
may
employ
fusion
mechan
virus
class
envelop
protein
studi
indic
sarscov
bind
target
cell
transmembran
spike
protein
might
chang
conform
associ
residu
region
form
oligomer
structur
lead
fusion
viral
targetcel
membran
therefor
suggest
use
potent
inhibitor
peptid
target
develop
therapeut
drug
sarscov
studi
mab
bound
hrc
region
might
inhibit
hrn
hrc
form
coiledcoil
structur
requir
viralcellular
membran
fusion
neutral
infect
sarscov
block
viru
entri
vero
cell
howev
data
show
rabbit
antisera
immun
recombin
spike
protein
react
peptid
data
shown
rabbit
antisera
could
differ
viru
neutral
effect
recent
angiotensinconvert
enzym
report
function
receptor
sar
coronaviru
vero
cell
li
et
al
receptorassoci
epitop
sarscov
spike
protein
identifi
within
residu
probeantibodi
complex
separ
free
probe
electrophoresi
nondenatur
polyacrylamid
gel
western
blot
finish
describ
materi
method
posit
probeantibodi
complex
indic
right
studi
investig
map
neutral
epitop
recogn
rabbit
antisera
summari
mous
mab
rais
recombin
spike
protein
effect
suffici
neutral
sarscov
infect
vero
cell
result
studi
show
mab
specif
recogn
heptad
repeat
region
spike
protein
might
neutral
infect
cell
sarscov
bind
neutral
epitop
locat
hrc
spike
protein
monoclon
antibodi
differ
bind
synthet
peptid
mimick
region
implic
presenc
sever
potenti
neutral
epitop
thu
might
practic
prevent
human
infect
sarscov
recombin
subunit
vaccin
synthet
peptid
mimick
optim
amino
acid
residu
viru
neutral
epitop
spdvdlgdisgina
heptad
repeat
region
spike
protein
